Develops regenerative medicine treatments for gastro-intestinal disorders.
Jun 2026Revenue $982K/yrExpenses $7.69M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Harvard Apparatus Regenerative Technology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $982K and expenses $7.69M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $704K | $7.62M | −$6.92M |
| Dec 2024 | $430K | $8.16M | −$7.73M |
| Dec 2023 | $103K | $9.09M | −$8.99M |
| Dec 2021 | $0.00 | $8.64M | −$8.64M |
| Dec 2020 | $0.00 | $5.33M | −$5.33M |
| Dec 2019 | $0.00 | $8.87M | −$8.87M |
| Dec 2018 | $0.00 | $7.84M | −$7.84M |
| Dec 2017 | $0.00 | $11.5M | −$11.5M |
| Dec 2016 | $82.0K | $12.2M | −$12.1M |
| Dec 2015 | $118K | $11.8M | −$11.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.